FDY-5301

· Faraday Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FDY-5301, covering 2021-12-14 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation in STEMI Patients Using FDY-5301 [Phase 3]